Unitedhealth Group Inc (NYSE:UNH) price closed higher on Tuesday, April 16, jumping 5.22% above its previous close.
A look at the daily price movement shows that the last close reads $445.63. The company’s P/E ratio in the trailing 12-month period read 19.66. Taking into account the 52-week price action we note that the stock hit a 52-week high of $554.70 and 52-week low of $436.38. The stock subtracted -4.47% on its value in the past month.
Unitedhealth Group Inc, which has a market valuation of $432.28 billion. The company stock has a Forward Dividend ratio of 7.52, while the dividend yield is 1.60%. It is understandable that investor optimism is growing ahead of the company’s current quarter results.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give UNH a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell.
If we dive deeper into the stock’s performance we see the positive picture represented by the PEG ratio, currently standing at 1.47. The overview shows that UNH’s price is at present -0.59% off the SMA20 and -4.52% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 48.40, with weekly volatility standing at 1.98%. The indicator jumps to 1.59% when calculated based on the past 30 days. Unitedhealth Group Inc (NYSE:UNH)’s beta value is holding at 0.58, while the average true range (ATR) indicator is currently reading 10.80.
An analysis of the Unitedhealth Group Inc (NYSE:UNH) stock in terms of its daily trading volume indicates that the 3-month average is 4.46 million.
Current records show that the company has 924.00M in outstanding shares. The insiders’ percentage holdings are 0.19% of outstanding shares while the percentage share held by institutions stands at 90.45%. But the -10.94% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
